Atlas Trials

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Clinical trial NCT05101616 · SUSPENDED

Trial details

NCT number
NCT05101616
Sponsor
Shanghai Minimally Invasive Surgery Center
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2022-07-01
Primary completion
2025-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.